Analysis of Urinary Gene Expression of Epithelial-Mesenchymal Transition Markers in Kidney Transplant Recipients

被引:12
|
作者
Gomez-Alamillo, C. [1 ,2 ]
Benito-Hernandez, A. [2 ]
Ramos-Barron, M. A. [2 ]
Agueeros, C. [2 ]
Rodrigo, E. [1 ]
Ruiz, J. C. [1 ]
Sanchez, M. [2 ]
San Cosme, L. [2 ]
Arias, M. [1 ]
机构
[1] Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Dept Nephrol, Santander 39008, Cantabria, Spain
[2] Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, Nephrol & Kidney Transplant Immunol Lab, Santander 39008, Cantabria, Spain
关键词
CHRONIC ALLOGRAFT NEPHROPATHY; NONINVASIVE DIAGNOSIS; ACUTE REJECTION; GRAFT FUNCTION; FIBROGENESIS;
D O I
10.1016/j.transproceed.2010.07.051
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction. Renal graft dysfunction due to acute rejection, acute tubular necrosis, or anticalcineurin toxicity with development of interstitial fibrosis or tubular atrophy are the primary causes of graft failure. Determination of kidney function using the serum creatinine concentration demonstrates low sensitivity as a marker for the diagnosis, and kidney biopsy is an invasive procedure. The levels of urinary messenger RNA of genes that regulate epithelial-mesenchymal transition (EMT) can reflect early kidney damage. Thus, repeated transcriptome studies of these genes can provide information about the evolution of the graft, and possibly enable early diagnosis and treatment. Objective. To analyze the temporal relationships between early graft evolution and gene expression of EMT biomarkers. Methods. Of 70 kidney transplant procedures performed between January 1, 2007 and December 31, 2008, 42 were analyzed prospectively for 3 months. Analytical and clinical data were recorded, as well as histologic findings if available. Urine mRNA extraction was performed using a commercially available kit. RNA gene expression of EMT, angiotensinogen, epidermal growth factor receptor, E-cadherin, N-cadherin, transforming growth factor-beta, and bone morphogenetic protein 7 was determined at real-time quantitative polymerase chain reaction. beta 2-Microglobulin was used as a reference gene. Results. At 75 days posttransplantation, analysis revealed that angiotensinogen (mean [SD], 2.91 [0.70] vs 6.04 [1.24]; P = .04) and N-cadherin (1.01 [0.43] vs 4.31 [0.92]; P = .01) discriminate good evolution from acute rejection. Epidermal growth factor receptor (2.78 [0.66] vs 6.02 [1.09]; P = .33) and bone morphogenetic protein 7 (0.85 [0.33] vs 3.07 [1.37]; P = .04) discriminate good evolution vs delayed graft function. Conclusion. Differential gene expression at 75 days posttransplantation reflects differences related to initial histologic damage. This observation encourages design of a long-term longitudinal analysis with multiple markers to obtain early diagnosis and forecast the prognosis of graft dysfunction.
引用
收藏
页码:2886 / 2888
页数:3
相关论文
共 50 条
  • [1] EPITHELIAL TO MESENCHYMAL TRANSITION MARKERS IN KIDNEY TRANSPLANT RECIPIENTS: THE CERTITEM TRIAL
    Hertig, A.
    Kamar, N.
    Anglicheau, D.
    Moulin, B.
    Hazzan, M.
    De Ligny, B. Hurault
    Quere, S.
    Di Giambattista, F.
    Rondeau, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [2] EPITHELIAL TO MESENCHYMAL TRANSITION MARKERS IN KIDNEY TRANSPLANT RECIPIENTS: THE CERTITEM TRIAL
    Hertig, Alexandre
    Kamar, Nassim
    Anglicheau, Dany
    Moulin, Bruno
    Hazzan, Marc
    Ligny, Bruno Huraultde
    Di Giambattista, Fabienne
    Rondeau, Eric
    TRANSPLANT INTERNATIONAL, 2013, 26 : 201 - 201
  • [3] Epithelial to Mesenchymal Transition Markers in Kidney Transplant Recipients: The CERTITEM Trial
    Hertig, A.
    Kamar, N.
    Albano, L.
    Anglicheau, D.
    Durrbach, A.
    Vuiblet, V.
    Merville, P.
    Moulin, B.
    Hazzan, M.
    Lang, P.
    Touchard, G.
    De Ligny, B. Hurault
    Quere, S.
    Di Giambattista, F.
    Rondeau, E.
    TRANSPLANTATION, 2014, 98 : 81 - 81
  • [4] Epithelial to Mesenchymal Transition Markers in Kidney Transplant Recipients: The CERTITEM Trial.
    Hertig, A.
    Kamar, N.
    Albano, L.
    Anglicheau, D.
    Durrbach, A.
    Vuiblet, V.
    Merville, P.
    Moulin, B.
    Hazzan, M.
    Lang, P.
    Touchard, G.
    De Ligny, B. Hurault
    Quere, S.
    Di Giambattista, F.
    Rondeau, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 81 - 81
  • [5] Relation of Urinary Gene Expression of Epithelial-Mesenchymal Transition Markers With Initial Events and 1-Year Kidney Graft Function
    Gomez-Alamillo, C.
    Ramos-Barron, M. A.
    Benito-Hernandez, A.
    Rodrigo, E.
    Ruiz, J. C.
    Agueeros, C.
    Sanchez, M.
    Arias, M.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (09) : 2573 - 2576
  • [6] Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
    Shunichiro Nomura
    Yasutomo Suzuki
    Jun Akatsuka
    Yuki Endo
    Akira Shimizu
    Tsutomu Hamasaki
    Go Kimura
    Yukihiro Kondo
    BMC Urology, 20
  • [7] Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
    Nomura, Shunichiro
    Suzuki, Yasutomo
    Akatsuka, Jun
    Endo, Yuki
    Shimizu, Akira
    Hamasaki, Tsutomu
    Kimura, Go
    Kondo, Yukihiro
    BMC UROLOGY, 2020, 20 (01)
  • [8] MARKERS OF EPITHELIAL-MESENCHYMAL TRANSITION IN CHILDREN WITH CHRONIC KIDNEY DISEASE
    Musial, Kinga
    Bargenda, Agnieszka
    Zwolinska, Danuta
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [9] Epithelial-Mesenchymal Transition Markers Expression in Male Breast Cancer
    Reddy, A. Kanmatha
    Huda, F.
    Chowdhury, N.
    Jadli, M.
    Khare, V.
    Raj, N.
    Basu, S.
    Syed, A.
    Negi, P.
    BREAST, 2025, 80
  • [10] Expression Of Epithelial-Mesenchymal Transition Markers In Chronic Asthmatic Airway
    Makinde, T. O.
    Gaurav, R.
    Agrawal, D. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183